Hindson Benjamin J. (CIK 1786391) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-26). Recent activity: Sell TXG (13,818 shares), Sell TXG (11,595 shares), Buy TXG (88,816 shares), Sell TXG (7,826 shares), Sell TXG (8,283 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-26 | 10x Genomics, Inc. (TXG) | Title: President and Chief Scientific Officer | Sell | 13,818 | $870,860 |
| 2026-05-27 | 10x Genomics, Inc. (TXG) | Title: President and Chief Scientific Officer | Sell | 11,595 | $283,382 |
| 2026-03-02 | 10x Genomics, Inc. (TXG) | Title: President and Chief Scientific Officer | Buy | 88,816 | $0 |
| 2026-02-25 | 10x Genomics, Inc. (TXG) | Title: President and Chief Scientific Officer | Sell | 7,826 | $145,407 |
| 2025-11-25 | 10x Genomics, Inc. (TXG) | President and Chief Scientific Officer | Sell | 8,283 | $157,377 |
| 2025-08-26 | 10x Genomics, Inc. (TXG) | President and Chief Scientific Officer | Sell | 7,486 | $103,232 |
| 2025-05-27 | 10x Genomics, Inc. (TXG) | President and Chief Scientific Officer | Sell | 7,485 | $62,126 |
来源：SEC Form 4 申报文件 · 截至 2026-08-26